# Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA

> **NCT06393452** · PHASE2 · COMPLETED · sponsor: **Pelage Pharmaceuticals, Inc.** · enrollment: 78 (actual)

## Conditions studied

- Androgenetic Alopecia

## Interventions

- **DRUG:** PP405 0.05% Topical Gel
- **DRUG:** PP405 Topical Vehicle Gel

## Key facts

- **NCT ID:** NCT06393452
- **Lead sponsor:** Pelage Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-05
- **Primary completion:** 2025-07-16
- **Final completion:** 2025-10-01
- **Target enrollment:** 78 (ACTUAL)
- **Last updated:** 2025-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06393452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06393452, "Safety, Pharmacokinetics and Efficacy of PP405 in Adults With AGA". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06393452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*